Definition of intractable epilepsy

Neurosciences

Volumn 16, Issue 1, 2011, Pages 3-9

  Sinha, Shobhit ^a   Siddiqui, Khurram A ^a  

^a KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

BENIGN CHILDHOOD EPILEPSY; BRAIN MALFORMATION; CONSCIOUSNESS DISORDER; CONSENSUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPILEPTIC STATE; HUMAN; INFANTILE SPASM; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; MULTIDRUG RESISTANCE; NEUROSURGERY; ONSET AGE; QUALITY OF LIFE; RECURRENT DISEASE; REMISSION; REVIEW; SYMPTOM; TEMPORAL LOBE EPILEPSY; TREATMENT DURATION; TREATMENT RESPONSE;

ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 79951874551     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Weaver DF. Patient-relevant, rather than physician-friendly, definitions of disease: an improved definition of epilepsy. Am J Med 2005; 118: 805-806.
2. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998; 352: 1970-1973.
3. Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002; 43: 1402-1409.
4. Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. Early development of intractable epilepsy in children: a prospective study. Neurology 2001; 56: 1445-1452.
5. Sillanpaa M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia 1993; 34: 930-936.
6. Camfield P, Camfield C. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology 2005; 64: 973-975.
7. Dlugos DJ, Sammel MD, Strom BL, Farrar JT. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 2001; 57: 2259-2264.
8. Kwan P, Brodie MJ. Drug treatment of epilepsy: when does it fail and how to optimize its use? CNS Spectr 2004; 9: 110-119.
9. Obeid T. Stigma. An aspect of epilepsy not to be ignored. Saudi Med J 2008; 29: 489-497.
10. de Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav 2008; 12: 540-546.
11. Brandt C, Schoendienst M, Trentowska M, May TW, Pohlmann- Eden B, Tuschen-Caffier B, et al. Prevalence of anxiety disordersin patients with refractory focal epilepsy--a prospective clinic based survey. Epilepsy Behav 2010; 17: 259-263.
12. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003; 54: 388-398.
13. Sheth SG, Krauss G, Krumholz A, Li G. Mortality in epilepsy:driving fatalities vs other causes of death in patients with epilepsy. Neurology 2004; 63: 1002-1007.
14. Walczak TS, Leppik IE, D'Amelio M, Rarick J, So E, Ahman P, et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001; 56: 519-525.
15. Thompson PJ, Duncan JS. Cognitive decline in severe intractable epilepsy. Epilepsia 2005; 46: 1780-1787.
16. Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P. Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 2007; 48: 2224-2233.
17. Strzelczyk A, Reese JP, Dodel R, Hamer HM. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008; 26: 463-476.
18. Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003; 60: 538-547.
19. Freitag H, Tuxhorn I. Cognitive function in preschool children after epilepsy surgery: rationale for early intervention. Epilepsia 2005; 46: 561-567.
20. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319.
21. Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345: 311-318.
22. Loscher W, Schmidt D. Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia 2006; 47: 1253-1284.
23. Marchi N, Gonzalez-Martinez J, Nguyen MT, Granata T, Janigro D. Transporters in drug-refractory epilepsy: clinical significance. Clin Pharmacol Ther 2010; 87: 13-15.
24. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003; 348: 1442-1448.
25. Kwan P, Poon WS, Ng HK, Kang DE, Wong V, Ng PW, et al. Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression. Pharmacogenet Genomics 2008; 18: 989-998.
26. Aronica E, Gorter JA, Jansen GH, Leenstra S, Yankaya B, Troost D. Expression of connexin 43 and connexin 32 gapjunction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol 2001; 101: 449-459.
27. Arts WF, Geerts AT, Brouwer OF, Boudewyn Peters AC, Stroink H, van Donselaar CA. The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia 1999; 40: 726-734.
28. Kwan P, Brodie MJ, Epilepsy after the first drug fails: substitution or add-on? Seizure 2000; 9: 464-468.
29. Berg AT, Levy SR, Testa FM, D'Souza R. Remission of epilepsy after two drug failures in children: a prospective study. Ann Neurol 2009; 65: 510-519.
30. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007; 62: 375-381.
31. Callaghan BC, Anand K, Hesdorffer D, Hauser WA, French JA. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007; 62: 382-389.
32. Spooner CG, Berkovic SF, Mitchell LA, Wrennall JA, Harvey AS. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006; 67: 2147-2153.
33. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. Classification system for malformations of cortical development: update 2001. Neurology 2001; 57: 2168-2178.
34. Whiting S, Farrell K, Wirrell E. Diseases and syndromes associated with intractable epilepsy. Adv Neurol 2006; 97: 443-462.
35. Nolan MA, Sakuta R, Chuang N, Otsubo H, Rutka JT, Snead OC 3rd, et al. Dysembryoplastic neuroepithelial tumors in childhood: long-term outcome and prognostic features. Neurology 2004; 62: 2270-2276.
36. Nordli DR Jr. Infantile seizures and epilepsy syndromes. Epilepsia 2002; 43 Suppl 3: 11-16. Review.
37. Wheless JW, Kim HL. Adolescent seizures and epilepsy syndromes. Epilepsia 2002; 43 Suppl 3: 33-52. Review.
38. Berg AT, Levy SR, Novotny EJ, Shinnar S. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 1996; 37: 24-30.
39. Brorson LO, Wranne L. Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia 1987; 28: 324-330.
40. Casetta I, Granieri E, Monetti VC, Gilli G, Tola MR, Paolino E, et al. Early predictors of intractability in childhood epilepsy: a community-based case-control study in Copparo, Italy. Acta Neurol Scand 1999; 99: 329-333.
41. Berg AT, Vickrey BG, Langfitt JT, Sperling MR, Walczak TS, Shinnar S, et al. The multicenter study of epilepsy surgery: recruitment and selection for surgery. Epilepsia 2003; 44: 1425-1433.
42. Berg AT, Vickrey BG, Testa FM, Levy SR, Shinnar S, DiMario F, et al. How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol 2006; 60: 73-99.
43. Picot MC, Baldy-Moulinier M, Daurès JP, Dujols P, Crespel A. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 2008; 49: 1230-1238.
44. Al Hail H, Sokrab T, Hamad A, Kamran S, Hamad A, Khalid A. Epidemiology and Etiology of Intractable Epilepsy in Qatar. Qatar Medical Journal 2004; 13 (1).
45. Berg AT, Kelly MM. Defining intractability: comparisons among published definitions. Epilepsia 2006; 47: 431-436.
46. Kwan P, Brodie MJ. Definition of refractory epilepsy: defining the indefinable? Lancet Neurol 2010; 9: 27-29.
47. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-1077.